TABLE 6Stroke prevention strategies compared by Mazumdar et al.55

Frequency and duration of TCD scanningDuration of transfusion for high-risk patients
Annual to age 16 yearsMonthly transfusions for life
Annual to age 16 yearsTransfusion to age 18 years
Biannual to age 16 yearsTransfusion to age 18 years
Annual to age 10 yearsTransfusion to age 18 years
Once at 2 years of ageTransfusion to age 18 years
No screeningNo transfusion

From: 2, Background

Cover of The Clinical Effectiveness and Cost-Effectiveness of Primary Stroke Prevention in Children with Sickle Cell Disease: A Systematic Review and Economic Evaluation
The Clinical Effectiveness and Cost-Effectiveness of Primary Stroke Prevention in Children with Sickle Cell Disease: A Systematic Review and Economic Evaluation.
Health Technology Assessment, No. 16.43.
Cherry MG, Greenhalgh J, Osipenko L, et al.
Southampton (UK): NIHR Journals Library; 2012 Nov.
© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.